Why is Torrent Pharma falling/rising?

As of 10-Nov, Torrent Pharmaceuticals Ltd. is experiencing a significant rise in its stock price, currently at Rs 3,819.95, reflecting an increase of Rs 240.45 or 6.72%. The stock has recently hit a new 52-week high of Rs 3,835.15 and has outperformed its sector by 5.67%. Over the past two days, it has gained 7.47%, and it opened with a gain of 3.18% today. The stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend. Positive factors contributing to this rise include high management efficiency, a low debt-to-EBITDA ratio, and consistent positive results over the last nine quarters, which have bolstered investor confidence. However, there are concerns regarding long-term growth due to a relatively low annual net sales growth rate of 8.22% over the past five years. In the broader market context, Torrent Pharmaceuticals has outperformed the benchmark Sensex, which has seen a decline of 0.53% over the past week, while the stock itself has risen by 5.29%. This contrast highlights the stock's strong performance relative to the overall market. Additionally, the company's high institutional holdings at 25.2% suggest that knowledgeable investors are backing the stock, further supporting its price increase. Despite the positive momentum, the stock's valuation concerns, indicated by a high PEG ratio of 2.4, may pose risks for future growth, but the current market sentiment remains bullish.